Ferriprox FDA Approval History
Last updated by Judith Stewart, BPharm on May 3, 2021.
FDA Approved: Yes (First approved October 14, 2011)
Brand name: Ferriprox
Generic name: deferiprone
Dosage form: Tablets and Oral Solution
Company: ApoPharma Inc.
Treatment for: Thalassemia, Iron Overload, Anemia, Sickle Cell
- thalassemia syndromes
- sickle cell disease or other anemias.
Development timeline for Ferriprox
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.